List view / Grid view




Actavis to acquire Auden Mckenzie for £306m

27 January 2015 | By Actavis

Actavis plc and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately…


Michael Cann picks up the reins at the BGMA

26 May 2010 | By College Hill

Michael Cann, Director Generics at Actavis, took over as Chairman of the BGMA at the Association’s AGM in London on 26 May. He replaces Kim Innes of Teva, who will serve as Vice Chair for a year.